Pacific Biosciences Of California reported $1.08B in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Accelerate Diagnostics AXDX:US 35.72M 8.86M
Agilent A:US $ 1484M 56M
Bruker BRKR:US $ 573M 35.1M
Danaher DHR:US $ 2552M 4770M
Fluidigm FLDM:US $ 29.31M 1.55M
General Electric GE:US $ 24955M 2495M
Genmark Diagnostics GNMK:US $ 40.57M 17.24M
Illumina ILMN:US $ 1080M 3116M
Luminex LMNX:US $ 271.56M 37.85M
Myriad Genetics MYGN:US $ 295.2M 176.8M
Nanostring Technologies NSTG:US $ 107.17M 53.21M
Oxford Immunotec Global OXFD:US $ 160.62M 4.87M
Pacific Biosciences Of California PACB:US $ 1079.89M 620.1M
Perkinelmer PKI:US $ 487.37M 85.44M
Quidel QDEL:US $ 578.45M 14.78M
Thermo Fisher Scientific TMO:US $ 12027M 5004M
Waters WAT:US $ 655.19M 195.14M